Show simple item record

dc.contributor.authorYang, Xiaolin
dc.contributor.authorKulmala, Janne
dc.contributor.authorHakonen, Harto
dc.contributor.authorHirvensalo, Mirja
dc.contributor.authorRovio, Suvi P.
dc.contributor.authorPahkala, Katja
dc.contributor.authorKukko, Tuomas
dc.contributor.authorHutri-Kähönen, Nina
dc.contributor.authorRaitakari, Olli T.
dc.contributor.authorTammelin, Tuija H.
dc.date.accessioned2021-08-18T06:00:03Z
dc.date.available2021-08-18T06:00:03Z
dc.date.issued2021
dc.identifier.citationYang, X., Kulmala, J., Hakonen, H., Hirvensalo, M., Rovio, S. P., Pahkala, K., Kukko, T., Hutri-Kähönen, N., Raitakari, O. T., & Tammelin, T. H. (2021). Tracking and Changes in Daily Step Counts among Finnish Adults. <i>Medicine and Science in Sports and Exercise</i>, <i>53</i>(8), 1615-1623. <a href="https://doi.org/10.1249/MSS.0000000000002621" target="_blank">https://doi.org/10.1249/MSS.0000000000002621</a>
dc.identifier.otherCONVID_99293825
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/77391
dc.description.abstractPurpose: This study aimed to investigate the tracking and changes of steps per day in adults and their determinants over 13 yr. Methods: A total of 2195 subjects (1236 women) 30–45 yr of age were randomly recruited from the ongoing Cardiovascular Risk in Young Finns Study in 2007 and were followed up in 2020. Steps per day, including both total and aerobic steps per day, were monitored for seven consecutive days with a pedometer in 2007–2008 and 2011–2012 and with an accelerometer in 2018–2020. Tracking was analyzed using Spearman’s correlation. Stability and changes of steps per day over time in both low-active and high-active groups (based on median values) were described by percentage agreements, kappa statistics, and logistic regression. Associations of sex, age, and body mass index with the initial number and changes in steps per day were analyzed using linear growth curve modeling. Results: Tracking correlations of total steps per day at 4-, 9-, and 13-yr intervals were 0.45–0.66, 0.33–0.70, and 0.29–0.60, while corresponding correlations for aerobic steps per day were 0.28–0.55, 0.23–0.52, and 0.08–0.55, respectively. Percentage agreements were higher than 54%, and kappa statistics ranged from slight to fair over time. Compared with the low-active group, the high-active group at baseline had a higher probability of being active later in adulthood. Female sex and higher age were associated directly with the initial number of steps per day and inversely with changes in the number of steps per day. Body mass index was inversely associated with the initial number of steps per day and changes in the number of total steps per day. Conclusion: The 13-yr tracking of steps per day in adulthood was found to be low to moderately high. Daily ambulatory activity is essential to maintaining an active lifestyle throughout adulthood. Changes in the amount of adult steps per day vary by sex, age, and BMI.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherWolters Kluwer
dc.relation.ispartofseriesMedicine and Science in Sports and Exercise
dc.rightsCC BY-NC-ND 4.0
dc.titleTracking and Changes in Daily Step Counts among Finnish Adults
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202108184554
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.description.reviewstatuspeerReviewed
dc.format.pagerange1615-1623
dc.relation.issn0195-9131
dc.relation.numberinseries8
dc.relation.volume53
dc.type.versionpublishedVersion
dc.rights.copyright© 2021 the Authors
dc.rights.accesslevelopenAccessfi
dc.subject.ysofyysinen aktiivisuus
dc.subject.ysoaskelmittarit
dc.subject.ysoaikuiset
dc.subject.ysopitkittäistutkimus
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p23102
jyx.subject.urihttp://www.yso.fi/onto/yso/p23404
jyx.subject.urihttp://www.yso.fi/onto/yso/p5590
jyx.subject.urihttp://www.yso.fi/onto/yso/p14610
dc.rights.urlhttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.relation.doi10.1249/MSS.0000000000002621
jyx.fundinginformationThe present study was financially supported by the Academy of Finland (grant nos. 322098, 286284, and 134309 [EYE]; 126925, 121584, 124282, and 129378 [SALVE]; 117787 (GENDI); and 41071 [SKIDI]); the Social Insurance Institution of Finland; the Finnish Ministry of Education and Culture (grant no. 415635, XY); the Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere, and Turku University Hospitals (grant no. X51001); the Juho Vainio Foundation; the Paavo Nurmi Foundation; the Finnish Foundation for Cardiovascular Research; the Finnish Cultural Foundation; the Sigrid Juselius Foundation; the Tampere Tuberculosis Foundation; the Emil Aaltonen Foundation; the Yrjö Jahnsson Foundation; the Signe and Ane Gyllenberg Foundation; the Diabetes Research Foundation of Finnish Diabetes Association; the EU Horizon 2020 (grant no. 755320 for TAXINOMISIS and grant no. 848146 for To Aition); the European Research Council (grant no. 742927 for MULTIEPIGEN project); and the Tampere University Hospital Supporting Foundation. KP is founded by an Academy of Finland research fellowship (no. 322112).


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY-NC-ND 4.0
Except where otherwise noted, this item's license is described as CC BY-NC-ND 4.0